Amy Hicks, PhD, is a scientific leader with over 10 years of experience in preclinical pharmacology, focusing on gene therapy and rare diseases. Educated at Wake Forest University, Amy held several prominent positions, including Director of the In Vivo Pharmacology Group at Deep Genomics and Principal Scientist at Entrada Therapeutics, where they played key roles in successful collaborations and regulatory approvals. Their work has contributed to significant advancements in neuromuscular disease therapies and they have authored multiple publications in top-tier journals. Passionate about developing innovative treatments, Amy has a proven track record in leading cross-functional teams and managing substantial research initiatives.
This person is not in any teams
This person is not in any offices